TF
NEO icon

TimeScale Financial’s NeoGenomics NEO Stock Holding History

TimeScale Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-98
Closed -$4K – 463
2020
Q3 		$4K Hold
98
– – ﹤0.01% 370
2020
Q2 		$3K Hold
98
– – ﹤0.01% 377
2020
Q1 		$2K Hold
98
– – ﹤0.01% 373
2019
Q4 		$2K Buy
+98
New +$2.33K ﹤0.01% 472

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

TimeScale Financial's NEO Position: Q4 2020 in Review

TimeScale Financial sold out of NeoGenomics (NEO) in Q4 2020, closing a stake of 98 shares — an estimated $4K sold.

TimeScale Financial first reported a position in NEO in Q4 2019 and held it in 4 quarters. The position peaked at $4K in Q3 2020. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

  • TimeScale Financial reported no remaining NeoGenomics position as of Q4 2020 after selling out during the quarter.
  • TimeScale Financial sold 98 NeoGenomics shares in Q4 2020, an estimated $4K.
  • TimeScale Financial first reported a position in NeoGenomics in Q4 2019 and held it in 4 quarters.
  • TimeScale Financial's NeoGenomics position peaked at $4K in Q3 2020.
  • 340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on TimeScale Financial's 13F filing for Q4 2020, filed 28 Jan 2021.